A cutting-edge experimental drug cuts nearly in half the risk of death among patients with a rare but aggressive cancer of the eye.
from WebMD Health https://ift.tt/2RSQmE3
A cutting-edge experimental drug cuts nearly in half the risk of death among patients with a rare but aggressive cancer of the eye.
0 comments:
Post a Comment